JSCAI BEATS

Leaders, Sahil Parikh, MD, FSCAI, Pietro Di Santo, MD, & Carlos Mena-Hurtado, MD FSCAI, discuss key findings from the ULTRAsound Assessment of Access SITe COMplications study, highlighting the superior accuracy of point-of-care ultrasound (POCUS) in detecting pseudoaneurysms compared to physical examination alone. The authors explore how integrating POCUS into routine practice could enhance early complication detection, improving patient outcomes and reducing healthcare costs. With advancements in ultrasound accessibility, this discussion underscores the growing role of POCUS in optimizing post-procedural care.Read the related article: https://doi.org/10.1016/j.jscai.2024.102516

Physiological changes in the coronary circulation associated with PCI for CTOs remain largely unknown. This systematic review and meta-analysis, published in JSCAI, aimed to investigate physiological changes in the CTO and donor vessel before and immediately after PCI, as well as at follow-up.Dean Kereiakes MD MSCAI, Javier Escaned MD PhD, Emmanouil Brilakis MD PhD FSCAI, and William Fearon MD FSCAI discuss the article highlights in this video interview. Read the article: https://doi.org/10.1016/j.jscai.2024.102452

A Bayesian network meta-analysis of 30 studies involving 8,016 patients compared 12 PCI strategies for treating DES-ISR. Prakash Raj Oli, MBBS, Andrew Goldsweig, MD, FSCAI, Evan Shlofmitz, DO, discuss these findings in an insightful video interview, emphasizing key clinical takeaways and the need for further research.

Drs. Andrew Goldsweig, MD, MS, FSCAI, Ivan Hanson, MD, FSCAI, Bill O’Neil, MD, MSCAI, Srihari Naidu, MD, FSCAI & M. Babar Basir, DO, FSCAI discuss this original research in JSCAI highlighting the characteristics and outcomes of the SCAI stage E shock patients with AMICS undergoing PCI who improved to stage C or D within 24 hours of Impella support (“responders”) vs those patients who remained in stage E (“nonresponders”).

Cindy Grines, MD, MSCAI, Rajesh Rajan, MD, and Mirvat Alasnag, MD, FSCAI, discuss the first study to validate the SCAI-Cardiogenic Shock Working Group stages in a large cohort of AMICS patients in the Gulf region. The findings reveal that higher SCAI stages (D/E) are strongly linked to significantly worse short- and long-term survival outcomes. Patients in advanced stages of shock face more than a threefold higher risk of mortality, underscoring the critical importance of early identification and aggressive treatment to improve survival. Watch the video interview now.Read the article: https://doi.org/10.1016/j.jscai.2024.102461

The EMPOWER CAD study is a postmarket, prospective, multicenter, single-arm observational study evaluating the Shockwave Coronary IVL system for treating women with calcified coronary artery disease. This conversation features Dean Kereiakes, MD, MSCAI, Margaret McEntegart, MD, FSCAI, Suzanne Baron, MD, FSCAI, & Robert Riley, MD, FSCAI, as they highlight the EMPOWER CAD study and address the underrepresentation of women in interventional cardiology clinical trials.

The mechanistic association between the hydraulic forces generated during contrast injection and the risk of coronary injury is poorly understood. The authors evaluate whether contrast injections increase intracoronary pressures beyond resting levels and estimate the risk of hydraulic propagation of coronary dissections. Findings suggest that pressure increases are negligible beyond the catheter tip, reducing the likelihood of injuries in distal coronary segments. Dean Kereiakes, MD, MSCAI, Daniel Chamié, and Ricardo Petraco, MD, PhD, discuss the study’s highlights in an accompanying video interview.

Read the article: https://doi.org/10.1016/j.jscai.2024.102396